Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in Catalonia, Spain
E Burn, E Roel, A Pistillo, S Fernández-Bertolín… - Nature …, 2022 - nature.com
Population-based studies can provide important evidence on the safety of COVID-19
vaccines. Here we compare rates of thrombosis and thrombocytopenia following vaccination
against SARS-CoV-2 with the background (expected) rates in the general population. In
addition, we compare the rates of the same adverse events among persons infected with
SARS-CoV-2 with background rates. Primary care and linked hospital data from Catalonia,
Spain informed the study, with participants vaccinated with BNT162b2 or ChAdOx1 …
vaccines. Here we compare rates of thrombosis and thrombocytopenia following vaccination
against SARS-CoV-2 with the background (expected) rates in the general population. In
addition, we compare the rates of the same adverse events among persons infected with
SARS-CoV-2 with background rates. Primary care and linked hospital data from Catalonia,
Spain informed the study, with participants vaccinated with BNT162b2 or ChAdOx1 …
以上显示的是最相近的搜索结果。 查看全部搜索结果